LVP PHARMA:
LVP PHARMA ACQUIRES 167 MILLION SHARES IN EGYPT'S RAMEDA FOR EGP 846.5 MILLION
LVP PHARMA RAISES STAKE IN EGYPT'S RAMEDA TO 31.498% FROM 23.15%
LVP PHARMA INTENDS TO SUPPORT COMPANY AND ENHANCE SUSTAINABILITY OF ITS BUSINESS
LVP Pharma Raises Stake In Egypt's Rameda To 31.498%
Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda on 6ix
Story so far
Earlier from Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda
- Egypt's RAMEDA Appoints Sherif Ahmed Mohamed El Akhdar As Chairman
- Egypt's Rameda Q1 Standalone Profit EGP 105.2 Million
- Rameda FY Consol Profit EGP 313.2 Million
- LVP Pharma Raises Stake In RAMEDA To 23.15% - EGX
- LVP Pharma Raises Stake In RAMEDA To 11.8% - EGX
Later from Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda
All Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda news releasesFollow Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda into a list and get an email when it puts out news.
Follow Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda